Phenylephrine and the risk of atrial fibrillation in critically ill patients: a multi-centre study from eICU database

This evidence positions phenylephrine as a modifiable new AF risk factor in critical care, supporting risk-aware vasopressor selection through benefit-harm analysis.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-03-26
DOI
https://doi.org/10.3389/fphar.2025.1478961
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenylephrine and the risk of atrial fibrillation in critically ill patients: a multi-centre study from eICU database

Heng Li, Weichao Li, WeiXian Xie, Zhiming Huang et al.
Frontiers in Pharmacology
Atrial Fibrillation Management and Outcomes
article

Phenylephrine and the risk of atrial fibrillation in critically ill patients: a multi-centre study from eICU database

Heng Li, Weichao Li, WeiXian Xie, Zhiming Huang, Gu xun-hu
article en

Abstract

This evidence positions phenylephrine as a modifiable new AF risk factor in critical care, supporting risk-aware vasopressor selection through benefit-harm analysis.

Frontiers in PharmacologyVol. 16
Nanchang University (CN), Second Affiliated Hospital of Nanchang University (CN), Guangzhou Medical University (CN)
Good health and well-being
Openalex Percentile: Top 91%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.